Paramount Skydance Corp has offered solutions to EU competition watchdogs regarding its massive Warner Bros Discovery acquisition. The comp...

The French multinational ⁠said in a press release it would pay $3.1 billion for the whole of Cognite in an ⁠all cash deal.

Britain is considering intervening in Paramount's proposed $110 billion takeover of Warner Bros Discovery, potentially delaying the deal de...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

A $1 billion fund, American Ventures, backed by Donald Trump Jr. and Eric Trump, is generating substantial paper profits by investing in sm...

Cargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...

US Secretary of State Marco Rubio on Thursday warned that Iranian tolls on ships passing the Strait of Hormuz would spread to other waterwa...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Investor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...